嚴重急性呼吸道症候群

Severe Acute Respiratory Syndrome

10.7023/TJFM.200312.0145

陳國東(Kow-Tong Chen)；楊志元(Jyh-Yuan Yang)；林旭龍(Sol L. Lin)；唐麗慧(Li-Hui Tang)

severe acute respiratory syndrome ； cornavirus ； case-fatality rate

台灣家庭醫學雜誌

13卷4期（2003 / 12 / 01）

145 - 156

繁體中文

嚴重急性呼吸道症候群（severe acute respiratory syndrome, SARS）是經由感染變種冠狀病毒（SARS CoV）所引起。SARS冠狀病毒的傳染途徑主要是經由近距離密切接觸感染。自2003年3月世界衛生組織要求世界各國加強通報嚴重急性呼吸道症候群疫情以來，已有超過32個以上國家通報，到2003年7月11日，可能病例已有8,437例，其中813例死亡，病例致死率約9.6%。台灣地區自2003年3月14日接獲第一例SARS通報病例，到7月11日可能病例共有669例，其中72例死亡，病例致死率約10.8%。SARS病毒感染後造成嚴重併發症及死亡，不僅威脅到人類生命的安全，也造成無以數計的經濟損失。了解SARS並做好準備是減低SARS所造成的罹病與死亡的重要方法之一。本文回顧SARS的文獻，冀能加強醫護人員對SARS的認識，以便做好周全的預防措施。

Severe acute respiratory syndrome (SARS) is caused by SARS CoV through close contact with SARS patients. SARS has been reported in over 32 countries since the World Health Organization (WHO) issued a global alert in March 2003. Until July 11, 2003, 8437 probable SARS cases and 813 deaths (case fatality rate=9.6%) were reported in the world. In Taiwan, the first SARS case was reported on March 14, 2003. Since then, 669 probable cases and 72 deaths (case fatality rate=10.8%) were reported. SARS caused severs complication and death. It not only threatened the life of all people, but also caused economic bankruptcy in the world. To understand SARS is one of the most important measures to reduce the morbidity and mortality caused by SARS. We reviewed the current knowledge on SARS and underscored the prevention and intervention efforts.

1. Clinical course and management of SARS in health- care workers in Toronto: a case series
2. Baudouin S,Bluouenthal S,Cooper B(2002).Non-invasive ventilate in acute respiratory failure.Thorax,57,192-211.
3. Booth CM,Matukas LM,Tomlinson GA(2003).al: Clinical features and short-term outcomes of 144 patients with SARS in the great Toronto area.JAMA,289,2801-2809.
4. Emerg Infect Dis
5. Brown EG,Tetro JA(2003).Comparative analysis of the SAKS coronavirus genome: a good start to a long joumey.Lancet,361,1756-1757.
6. CDC(2003).Severe acute respiratory syndrome - Taiwan, 2003.MMWR Morb Mort Wkly Rep,52,461-466.
7. CDC(2003).Update: Outbreak of severe acute respiratory syndrome-Worldwide, 2003..MMWR Morb Mort Wkly Rep,52,241-248.
8. CDC(2003).Cluster of severe acute respiratory syndrome cases among protected health care workers - Toronto, April 2003..MMWR Morb Mort Wkly Rep,52,433-436.
9. Infection Control Precautions for Aerosol-generating procedures on patients who have suspected Severe Acute Respiratory Syndrome
10. CDC(2003).Outbreak of severe acute respiratory syndrome-worldwide.MMWR Morb Mort Wkly Rep,52,226-228.
11. CDC(2003).Severe Acute Respiratory Syndrome - Singapore, 2003..MMWR Morb Mort Wkly Rep,52,405-411.
12. Cinatl J,Morgenstern B,Bauer G,Chandra P,Rabenau H,Doerr HW(2003).Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus.Lancet,361,2045-2046.
13. Cyanoski D(2003).Critics slam treatment for SARS as ineffective and perhaps dangerous.Nature,423,4.
14. Cyranoski D,Abbott A(2003).Virus detective seek source of SARS in China`s wild animals.Nature,423,467.
15. Drosten C,Gunther S,Preiser W(2003).Identification of a novel coronavirus in patients with severe acute respiratory syndrome.N Engl J Med,348,4967-4976.
16. Enserink M(2003).Infectious diseases: clues to the animal origins of SARS.Science,300,1351.
17. Hazelton PR,Gelderblom HR(2003).Electron microscopy for rapid diagnosis of infectious agents in emergent situations.Emerg infect Dis,9,294-303.
18. Holmes KV(2003).SARS coronaviurs: a new challenge for prevention and therapy.J Clin Invest,111,1605-1609.
19. Ijaz MK,Brunner AH,Sattar SA,Nair RC,Johnson-Lussenburg CM(1985).Survival characteristics of airborne human coronavirus 229E.J Gen Virol,66,2743-2748.
20. Karf M,Trussardi R(2001).New, azide-free transformation of expoxides into l,2-diamino compounds: synthesis of the anti-influenza neuraminidase inhibitor oseltamivir phosphate.J Organic Chemistry,66,2044-2051.
21. Ksiazek TG,Erdman D,Goldsmith CS(2003).A novel coronavirus associated with severe acute respiratory syndrome.N Engl J Med,348,1953-1966.
22. Lee N,Hui D,Wu A(2003).A major outbreak of severe acute respiratory syndrome in Hong Kong.N Engl J Med,348,1986-1994.
23. Lew TW,Kwek TK,Tai D(2003).Acute respiratory syndrome in critically ill patients with sever acute respiratory syndrome.JAMA,290,374-380.
24. Makela MJ,Puhakka T,Ruuskanen O(1998).Viruses and bacteria in the etiology of the common cold..J Clin Microbiol,36,539-542.
25. McIntosh K,Mandell GL,Bennett JE,Dolin R(eds.)(2000).Mandell, Douglas, and Bennett`s Principles and Practice of Infectious Diseases.Philadelphia:Churchill Living-stone, Inc..
26. Niederman MS,Mandell LA,Anzueto A(2001).Guidelines for the management of adults with community-acquired pneumonia.Am J Respir Crit Care Med,163,1730-1754.
27. Peiris JS,Chu CM,Cheng VC(2003).Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.Lancet,361,1767-1772.
28. Peiris JS,Lai ST,Poon LL(2003).Coronavirus as a possible cause of severe acute respiratory syndrome.Lancet,361,1319-1325.
29. Riley S,Fraser C,Donnelly C A(2003).Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions.Science,300,1961-1966.
30. Seto WH,Tsang D,Yung R(2003).Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome.Lancet,361,1519-1520.
31. Siddell S,Wege H,ter Meulen V(1983).The biology of coronaviruses.J Gen Virol,64,761-776.
32. Sizun J,Yu MW,Talbot PJ(2000).Survival of human coronaviruses 229E and OC43 in suspension after drying on surfaces: a possible source of hospital-acquired infections.J Hosp Infect,46,55-60.
33. So LKY,Lau ACW,Yam LYC,Cheung TMT(2003).Development of a standard treatment protocol for severe acute respiratory syndrome.Lancet,361,1615-1616.
34. WHO global conference on severe acute respiratory syndrome
35. Tsui PT,Kwok ML,Yuen H,Lai ST(2003).Severe acute respiratory syndrome: clinical outcome and prognostic correlates.Emerg Infect Dis,9,1064-1069.
36. Wang HJ,Ding YQ,Li X(2003).Fatal aspergillosis in a patient with SARS who has treated with corticosteroids.N Engl J Med,349,507-508.
37. Update 53 - Situation in Singapore and Hong Kong, interpretation of "areas with recent local transmission"
38. WHO(2003).Acute respiratory syndrome, China-Update.Wkly Epidemiol Rec,78,57.
39. First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network
40. WHO(2003).WHO Multicentre Collaborative Networks for Severe Acute Respiratory Syndrome diagnosis.Wkly Epidemiol Rec,78,121-122.
41. Situation in Toronto: detection of SARS-like virus in wild animals
42. Wong VWS,Dai D,Wu AK,Sung JJY(2003).Treatment of severe acute respiratory syndrome with convalescent plasma.Hong Kong Med J,9,199-201.
43. Alert, verification and public health management of SARS in the post-outbreak period
44. Cumulative number of reported probable cases
45. World Health Organization(2003).Multicentre Collaborative Network for Severe Acute Respiratory Syndrome Diagnosis: A multicentre collaboration to investigate the cause of severe acute respiratory syndrome.Lancet,36,1730-1733.
46. Case definitions for surveillance of severe acute respiratory syndrome
47. Wu W,Wang JF,Liu PM(2003).A hospital outbreak of severe acute respiratory syndrome in Guangzhou, China..China Med J,116,811-818.
48. Zhao Z,Zhang F,Xu M(2003).Description and Clinical treatment o fan early outbreak of severe acute respiratory syndrome in Guangzhou.PR China. J Med Microbiol,52,715-720.

1. 曾嬿芬、吳嘉苓(2006)。SARS的風險治理：超越技術模型。台灣社會學，11，57-109。
2. 廖欽彬（譯）、美馬達哉(2012)。病毒感染爆發的社會性效用：SARS。文化研究，14，384-404。
3. (2005)。醫學地理的熱門課題「新興傳染病」的研究。地理學報，41，45-64。